Strategies for Achieving Remission of Major Depressive Disorder
Target audience: Psychiatric-mental health nurses
Resource Download Available: Includes Transcript Synched to Slides, Handouts, and Faculty Panel Q&A
Learning Objectives
At the end of this activity, learners should be better able to:
1. Describe the impact of inadequate management of major depressive disorder (MDD) on patient outcomes
2. Incorporate updated MDD guidelines into clinical practice
3. Use strategies to improve patient adherence to the treatment plan
4. Implement effective approaches to achieving remission in patients with difficult-to-treat MDD
Accredited Provider
Continuing Nursing Education Provider Unit, Boston University School of Medicine
Accreditation Statement
Continuing Nursing Education Provider Unit, Boston University School of Medicine (BUSM), is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Contact Hours: 1.25 contact hours
Nurses will receive contact hours for the time required to complete the activity, after completion of the posttest with a score of 70% or greater and an evaluation form.
As part of our effort to improve the education that is presented and to gauge educational need, participants will receive a follow-up email with a link to a brief outcomes survey in approximately 60-90 days after completion of the session. Participation in the survey is voluntary.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and co-provided by In2MedEd. For questions regarding CNE contact hours, please contact the BUSM CME office at cme@bu.edu.
Date of original release: 01/20/2012
Date of expiration: 01/19/2013
Estimated time to complete: 1 hour and 15 minutes
System requirements: Microsoft(r) Windows(r) XP (32-bit), Windows Server(r) 2003 (32-bit), Windows Server 2008 (32-bit), Windows Vista(r) (32-bit), Windows 7 (32-bit and 64-bit) Internet Explorer 7.0 and above, Mozilla Firefox 4.0 and above, Google Chrome, Safari 5.0 and above, Opera 11 Adobe Flash Player 11.1 and above Macintosh Mac OS(r) X 10.6 and Mac OS X 10.7 Safari 5.0 and above, Mozilla Firefox 4.0 and above, Google Chrome, Opera 11 Adobe Flash Player 11.1 and above.
Faculty:
COURSE DIRECTOR:
Larry Culpepper, MD, MPH
Professor of Family Medicine
Boston University School of Medicine
Boston, MA
COURSE CHAIR and DESIGNATED NURSE PLANNER:
Barbara Jones Warren, PhD, CNS-BC, PMH
Professor of Clinical Nursing
Ohio State University College of Nursing
Columbus, OH
FACULTY
Madhukar Trivedi, MD
Professor and Director
Mood Disorders Research Program and Clinic
University of Texas Southwestern Medical Center
Dallas, TX
Denise Vanacore, PhD, CRNP, ANP, PsyNP, APRN, BC
Associate Professor of Nursing
Gwynedd Mercy College
Gwynedd, PA
Disclosures
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. Boston University Privacy Policy
Faculty Disclosures
Larry Culpepper, MD, MPH—Course Director
Consultant: AstraZeneca Pharmaceuticals LP; Forest Laboratories; Labopharm; Pfizer Inc;
Trovis Pharmaceuticals, LLC; Merck
Barbara Jones Warren, PhD, RN, CNS-BC, PMH—Course Chair and Designated Nurse Planner
Nothing to disclose with regard to commercial interests
Madhukar Trivedi, MD
Consultant: Abbott Laboratories; Abdl Ibrahim; Azko; Alkermes; AstraZeneca; Cephalon, Inc.; Evotek; Fabre-Kramer Pharmaceuticals, Inc.; Janssen Pharmaceutica Products, LP; Johnson & Johnson PRD; Libby; Medtronic; Neuronetics; Parke-Davis Pharmaceuticals, Inc.; SHIRE Development; Sierra; Tal Medical/Puretech Venture; Transept
Consultant/Speaker: Axon Advisors; Bristol-Myers Squibb Company; CME Institute of Physicians; Eli Lilly & Company; Forest Pharmaceuticals; GlaxoSmithKlne; Lundbeck; Meade Johnson; MedAvante; Otsuka Pharmaceuticals; Pamlab; Pfizer Inc; PgxHealth; Rexahn Pharmaceuticals; Sepracor; Takeda; VantagePoint; Wyeth-Ayerst Laboratories
Researcher: Agency for Healthcare Research & Quality; Corcept Therapeutics, Inc.; Cyberonics, Inc.; Merck; National Alliance for Research in Schizophrenia and Depression; National Institute of Mental Health; National Institute on Drug Abuse; Naurex; Novartis; Pharmacia & Upjohn; Predix Pharmaceuticals; Solvay Pharmaceuticals Inc.; Targacept; Valient
Denise Vanacore, PhD, CRNP, ANP, PsyNP, PRN, BC
Nothing to disclose with regard to commercial interests
Planning Committee Disclosures
In2MedEd: Nancy Baxter, MS; Barbara Saldinger, MS, MBA; Joan Weiss, MS
BUSM: Patti-Ann Collins, DNP, MSN/MBA, RN; Ilana Hardesty
Nothing to disclose with regard to commercial interests
Non-Endorsement of Products
Continuing Nursing Education Provider Unit, Boston University School of Medicine’s provider status refers only to continuing nursing education activities and does not imply that there is real or implied endorsement by Continuing Nursing Education Provider Unit, BUSM or ANCC of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
DISCLAIMER:
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
This activity is supported by an unrestricted educational grant from Otsuka America Pharmaceutical, Inc.
